This topic contains a solution. Click here to go to the answer

Author Question: As a practitioner, you would expect which parts of the physical examination to be affected by a dose ... (Read 86 times)

formula1

  • Hero Member
  • *****
  • Posts: 666
As a practitioner, you would expect which parts of the physical examination to be affected by a dose of atropine or other parasympatholytic agent?
 
  a. Gastrointestinal examination
  b. Neurologic examination
  c. Cardiac examination
  d. All of the above

Question 2

You administer an inhaled bronchodilator that is known to have adrenergic side effects. What cardiovascular clinical effect should you watch for in your patient?
 
  a. Bradycardia
  b. Tachycardia
  c. Bradypnea
  d. Tachypnea



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Alyson.hiatt@yahoo.com

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B




formula1

  • Member
  • Posts: 666
Reply 2 on: Jul 16, 2018
Excellent


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library